53.12
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$50.27
Aprire:
$50.93
Volume 24 ore:
1.65M
Relative Volume:
0.74
Capitalizzazione di mercato:
$8.33B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
56.51
EPS:
0.94
Flusso di cassa netto:
$245.03M
1 W Prestazione:
+3.31%
1M Prestazione:
+6.47%
6M Prestazione:
-32.51%
1 anno Prestazione:
-31.70%
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
(612) 379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Confronta TECH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
TECH
Bio Techne Corp
|
53.12 | 8.06B | 1.17B | 150.71M | 245.03M | 0.94 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-22 | Ripresa | Stephens | Overweight |
2025-07-09 | Iniziato | TD Cowen | Buy |
2025-05-30 | Iniziato | Wells Fargo | Overweight |
2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2025-03-18 | Iniziato | Evercore ISI | Outperform |
2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
2024-02-02 | Downgrade | Stifel | Buy → Hold |
2023-12-07 | Iniziato | UBS | Buy |
2023-08-28 | Iniziato | William Blair | Outperform |
2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2022-12-14 | Iniziato | Deutsche Bank | Buy |
2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
2022-08-25 | Iniziato | Credit Suisse | Outperform |
2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
2021-01-25 | Reiterato | The Benchmark Company | Buy |
2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2020-09-30 | Iniziato | Atlantic Equities | Overweight |
2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
2020-05-27 | Downgrade | Stifel | Buy → Hold |
2020-05-14 | Iniziato | The Benchmark Company | Buy |
2020-01-08 | Ripresa | Stephens | Overweight |
2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
2020-01-07 | Iniziato | Citigroup | Neutral |
2019-11-15 | Iniziato | Stifel | Buy |
2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
2018-10-17 | Iniziato | Goldman | Neutral |
2018-06-15 | Iniziato | Argus | Buy |
2017-07-13 | Iniziato | Wells Fargo | Market Perform |
2017-02-09 | Iniziato | Citigroup | Buy |
2017-01-18 | Iniziato | Deutsche Bank | Buy |
2016-11-10 | Ripresa | Leerink Partners | Outperform |
2015-01-21 | Reiterato | Robert W. Baird | Outperform |
2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Bio Techne Corporation Stock Analysis and ForecastFree Investment Community - Autocar Professional
Bio-Techne Corporation shares rise 1.99% after-hours as US stocks close higher. - AInvest
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
Envestnet Asset Management Inc. Sells 66,478 Shares of Bio-Techne Corp (NASDAQ:TECH) - Defense World
Bio-Techne’s Quarterly Earnings Preview: What You Need to Know - inkl
Bio-Techne’s Quarterly Earnings Preview: What You Need To Know - Barchart.com
Bio-Techne Schedules Q4 2025 Earnings Call: Full Fiscal Year Results Coming August 6 - Stock Titan
Bio-Techne to distribute Spear Bio’s ultrasensitive immunoassays - Yahoo Finance
Bio-Techne Corp (NASDAQ:TECH) Stake Lessened by M&T Bank Corp - Defense World
Analysts Set Bio-Techne Corp (NASDAQ:TECH) Price Target at $70.00 - Defense World
Why Bio Techne Corporation stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser
How Bio Techne Corporation stock performs during market volatilityFree Expert-Led Investment Training - Newser
What makes Bio Techne Corporation stock price move sharplyOptimized Return Investment Picks - Newser
Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH) - Yahoo Finance
Spear Bio partners with Bio-Techne to expand ultrasensitive assay access By Investing.com - Investing.com South Africa
Spear Bio partners with Bio-Techne to expand ultrasensitive assay access - Investing.com
Bio-Techne Secures 1000x More Sensitive Biomarker Detection Technology in Major Neuroscience Partnership - Stock Titan
Bio-Techne (TECH) Partners with Spear Bio for Advanced Biomarker Detection | TECH Stock News - GuruFocus
Revolutionary Alzheimer's Biomarker Detection: Bio-Techne's New Platform Achieves 1000x Higher Sensitivity - Stock Titan
Bio-techne’s technology supports FDA approval of rare skin disorder therapy - Investing.com
Bio-Techne's Simple Western Enables Breakthrough FDA Approval for Rare Skin Disease Gene Therapy - Stock Titan
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy - Yahoo Finance
Teacher Retirement System of Texas Makes New Investment in Bio-Techne Corp (NASDAQ:TECH) - Defense World
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Principal Financial Group Inc. - Defense World
Teacher Retirement System of Texas Acquires New Holdings in Bio-Techne Corp (NASDAQ:TECH) - Defense World
Scotiabank Has Lowered Expectations for Bio-Techne (NASDAQ:TECH) Stock Price - Defense World
Bio-Techne stock price target lowered to $75 by Scotiabank - Investing.com Canada
TD Cowen Begins Coverage on Bio-Techne (NASDAQ:TECH) - Defense World
Minnesota's highest-paid CEOs made 7% more, with highest paid making $59.4M - Star Tribune
Assessing Bio-Techne: Insights From 7 Financial Analysts - Benzinga
Bio-Techne (TECH) Receives Buy Rating with $65 Price Target from TD Cowen | TECH Stock News - GuruFocus
Bio-Techne (TECH): TD Cowen Initiates Coverage with Buy Rating | - GuruFocus
Vontobel Holding Ltd. Decreases Stake in Bio-Techne Corp (NASDAQ:TECH) - Defense World
5 Revealing Analyst Questions From Bio-Techne’s Q1 Earnings Call - Yahoo Finance
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
GAMMA Investing LLC Cuts Stake in Bio-Techne Corp (NASDAQ:TECH) - Defense World
Amalgamated Bank Purchases 222 Shares of Bio-Techne Corp (NASDAQ:TECH) - Defense World
Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)? - Yahoo Finance
How To Trade (TECH) - news.stocktradersdaily.com
Janney Montgomery Scott LLC Grows Stake in Bio-Techne Corp (NASDAQ:TECH) - Defense World
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock - Zacks Investment Research
Bio-Techne stock holds steady as Stifel maintains $60 price target - Investing.com
Is Bio-Techne Stock Underperforming The Nasdaq? - Barchart.com
Major Breakthrough: Bio-Techne and USP Join Forces to Transform Gene Therapy Development Process - Stock Titan
First Week of August 15th Options Trading For Bio-Techne (TECH) - Nasdaq
Bio-Techne (NASDAQ:TECH) stock performance lags Nasdaq Composite in recent years - Kalkine Media
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
How the (TECH) price action is used to our Advantage - news.stocktradersdaily.com
Bio-Techne Director Cashes Out in Significant Stock Sale - TipRanks
Bio-Techne at Goldman Sachs Conference: Strategic Growth Amid Challenges - Investing.com
TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts - Yahoo Finance
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):